Timeline

  • March 24, 2023

    Enrolled over 4000 participants!

  • December 7-8, 2022

    Fourth annual consortium meeting in NYC with the inaugural Biomarker Summit

  • July 2022

    Over 3000 participants are enrolled in PRECEDE

  • December 12-13, 2021

    Third annual consortium meeting in NYC

  • June 11, 2021

    Greater than 1000 participants enrolled in PRECEDE

  • December 6, 2020

    Second Annual PRECEDE Consortium Meeting, virtual

  • May 8, 2020

    First participant enrolled in PRECEDE, at NYU

  • April 29, 2020

    PRECEDE study protocol approved by sIRB

  • December 8-9, 2019

    First Annual PRECEDE Consortium Meeting in NYC

  • July 2019

    Pancreatic Cancer Early Detection Research Consortium (PRECEDE) name is adopted

  • June 2019

    Project Purple and IMPACT PDA International Consortium execute contract with Arbor Research for build of electronic data collection platform, biosample labeling and tracking, and site onboarding for the first 25 clinical sites

  • November 15, 2018 (World Pancreatic Cancer Day)

    Project Purple and NYU announce $1.25 million dollar gift to support early detection research

  • November 11-12, 2018

    First “Early Detection Collaboration Meeting”